Xu Yuekang, Harder Kenneth W, Huntington Nicholas D, Hibbs Margaret L, Tarlinton David M
The Walter and Eliza Hall Institute of Medical Research, Melbourne 3050, Australia.
Immunity. 2005 Jan;22(1):9-18. doi: 10.1016/j.immuni.2004.12.004.
Lyn, one of several Src-family tyrosine kinases in immune cells, is noted for its ability to negatively regulate signaling pathways through phosphorylation of inhibitory receptors, enzymes, and adaptors. Somewhat paradoxically, it is also a key mediator in several pathways of B cell activation, such as CD19 and CD180. Whether Lyn functions to promote or inhibit immune cell activation depends on the stimulus and the developmental state, meaning that the consequences of Lyn activity are context dependent. The importance of regulating Lyn activity is exemplified by the pathological conditions that develop in both lyn-/- and lyn gain-of-function mice (lynup/up), including lethal antibody-mediated autoimmune diseases and myeloid neoplasia. Here, we review the outcomes of altered Lyn activity within the framework of B cell development and differentiation and the circumstances that appear to dictate the outcome.
Lyn是免疫细胞中几种Src家族酪氨酸激酶之一,以其通过磷酸化抑制性受体、酶和衔接蛋白来负向调节信号通路的能力而闻名。有点矛盾的是,它也是B细胞激活的几种途径中的关键介质,如CD19和CD180。Lyn是促进还是抑制免疫细胞激活取决于刺激因素和发育状态,这意味着Lyn活性的后果取决于具体情况。调节Lyn活性的重要性在lyn基因敲除小鼠和Lyn功能获得性小鼠(lynup/up)中出现的病理状况中得到了体现,这些病理状况包括致死性抗体介导的自身免疫性疾病和髓系肿瘤。在这里,我们在B细胞发育和分化的框架内回顾Lyn活性改变的结果以及似乎决定结果的情况。